E

Eagle Pharmaceuticals

D

EGRX

USD

-0.04

(-0.9195%)

Market Closed

757.00

حجم التداول

3.84

الربح لكل سهم

-

العائد الربحي

5.07059

P/E

55,849,958.37

حجم السوق

اليوم

-0.9195%

1 اسبوع

11.658%

1 شهر

-6.710%

6 اشهر

-21.494%

12 اشهر

-71.922%

بداية السنة

-17.591%

كل الوقت

0%

أصول ذات صلة

Title:
Eagle Pharmaceuticals

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا